Vaxcyte, Inc. (PCVX)
54.24
-1.24
(-2.24%)
USD |
NASDAQ |
Mar 18, 15:59
54.07
-0.16
(-0.30%)
After-Hours: 18:32
Vaxcyte EPS Diluted (Quarterly) : -1.881 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Corcept Therapeutics, Inc. | 0.1994 |
| Cytokinetics, Inc. | -1.495 |
| Rhythm Pharmaceuticals, Inc. | -0.7302 |
| Sutro Biopharma, Inc. | -6.699 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -246.51M |
| Total Expenses (Quarterly) | 246.51M |
| Enterprise Value | 6.541B |
| Earnings Yield | -10.52% |
| Normalized Earnings Yield | -10.52 |